Onyx Pharmaceuticals (ONXX) Announces 4.4M Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Onyx Pharma (ONXX) Prices 4.4M Offering; Sees Proceeds of $359M
January 16, 2013 8:38 AM ESTOnyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced the pricing of an underwritten public offering of 4,400,000 shares of its common stock. The gross proceeds to Onyx from this offering are expected to be approximately $358,600,000, before underwriting discounts and commissions and other estimated offering expenses... More
